VORTIO
Vortio is an online agency for search and social media analysis in Brazil. It provides advice to individual clients and agencies primarily in the area of social media. Besides analyzing companies’ own accounts and fan pages in social networks, Vortio also aggregates data on consumers and their online user behavior. On that basis, it develops measures and activities for targeted social media marketing. Vortio was founded by Braulio Medina and Dulio Matos.
VORTIO
Industry:
Analytics Social Media
Founded:
2012-01-01
Website Url:
http://www.vortio.com
Total Employee:
1+
Status:
Closed
Contact:
+55 21 4126-7418
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Apps For Business LocaWeb Locaweb Mail LocaWeb DNS
Similar Organizations
CrowdIndex
Crowd-based financial sentiment analysis
Hoxton United
Hoxton United is a digital and social media agency.
Imedia
IMEDIA offers media monitoring, media analysis, and social media PR analytics.
Social Metrics Pro
Social Metrics Pro is a social media analytics plugin for wordpress.
Current Employees Featured
Official Site Inspections
http://www.vortio.com
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 13.248.213.45
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Vortio"
Clinical-stage Cell and Genome Engineering | Vor Bio
Experts in HSC biology, genome engineering, cancer immunology, manufacturing, and clinical development driving towards a new solution to … See details»
Vor Bio - LinkedIn
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The company is focused on rapidly advancing … See details»
Vor Bio winding down as multiple biotechs downsize
1 day ago The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses … See details»
Vor Bio Announces Exploration of Strategic Alternatives to
May 8, 2025 Company Profile Vor Biopharma Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers … See details»
Vor Biopharma - Overview, News & Similar companies
View Vor Biopharma (www.vorbio.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and … See details»
News Releases - Vor Bio
3 days ago The Investor Relations website contains information about Vor Bio's business for stockholders, potential investors, and financial analysts. See details»
Vor Bio Looks for Exit in Challenging Funding Environment
May 8, 2025 The cell engineering company, co-founded by oncologist and writer Siddhartha Mukherjee, does not see a path forward for its pipeline of early-stage cell therapies for two … See details»
Vor Bio | Cell & Genome Engineering Biotechnology Company
Shield the healthy cells, expose the cancer - Vor Bio (also known as Vor Biopharma) aims to cure blood cancers through cell and genome engineering. See details»
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han …
Sep 30, 2024 Dr. Choi brings to Vor Bio over twenty-five years of experience in public and private investment management, business development, and corporate strategy within the … See details»
Vor Bio Announces $55.6 Million Private Placement | Vor Bio
Dec 27, 2024 Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial … See details»
Vision, Mission, and Values | Biotech Company | Vor Bio
Vor Bio's clear vision and mission gives everyone an opportunity to contribute to make a real difference for cancer patients. See details»
Vor Bio on LinkedIn: #vorbio
#VorBio CEO, Robert Ang and VP of Corporate Communications & Investor Relations, Sarah Spencer, will host a fireside chat on the CEO-Comms partnership and what it takes to build … See details»
Vor Bio Enters into Exclusive Global License Agreement with …
3 days ago The company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious … See details»
Board of Directors | Global Biotechnology Experience | Vor Bio
He also served as a member of the Board of Directors of the Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cell therapy and … See details»
Vor Bio Announces Exploration of Strategic Alternatives to …
May 8, 2025 In conjunction with the strategic process, Vor Bio implemented a workforce reduction of approximately 95% with a cost of approximately $10.9 million. Vor Bio plans to … See details»
Vor Bio Announces Exploration of Strategic Alternatives to …
May 8, 2025 In conjunction with the strategic process, Vor Bio implemented a workforce reduction of approximately 95% with a cost of approximately $10.9 million. Vor Bio plans to … See details»
The Online Reflection of Vor Bio
Aug 2, 2022 We spent a lot of time photographing our people – opening our lab, manufacturing space, and offices to really get a feel for the beating heart of our organization. See details»
Shielded transplant and CAR-T Cell Therapy Manufacturing …
Advantages of Our eHSC (engineered treatment-resistant Hematopoietic Stem Cells) Technology and Cell Therapy Manufacturing Process Our shielded transplant technology is designed to … See details»
Vor Bio Prices Underwritten Offering of Common Stock and …
CAMBRIDGE, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the pricing of an underwritten … See details»
Cultivating Company Culture: The Process Behind Vor Bio’s Core …
Sep 13, 2022 This was important to us to ensure our values resonated with employees at all levels of our organization. The next important step was to collect input from all key … See details»